Dasatinib Monohydrate Powder 863127-77-9 Anticancer Dasatinib Monohydrate

Dasatinib, also known as DASA tin IB, is a gray-white to yellow solid chemical. It is a potent anti-tumor drug primarily used for clinical treatment of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). It is specifically effective for patients in the chronic phase, accelerated phase, and blast phase who are resistant to or intolerant of imatinib mesylate.

Dasatinib is utilized across all stages of chronic myelogenous leukemia (CML) treatment. This includes patients with resistance or intolerance to imatinib mesylate (Gleevec). It is applicable for adult patients in the chronic phase, accelerated phase, lymphoid cell blast phase, and myeloid leukemia cell blast stage.